Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
We support FDA’s efforts to improve the safety and efficacy of POC BGMS used for hospitalized patients. However, we are concerned that, as written, the draft guidance would have serious unintended consequences for patients and hospitals, including placing patients at unnecessary risk.
The American Hospital Association (AHA) is pleased to support the Medical Care Access Protection Act of 2013 (S. 44).
The American Hospital Association (AHA) is pleased to support the Good Samaritan Health Professional Act (S. 2196). By extending to licensed, volunteer health professionals the same protective standards included in the Volunteer Protection Act of 1997, your legislation takes critical steps to help…
The American Hospital Association (AHA) is pleased to support the Good Samaritan Health Professional Act (H.R. 1733). By extending to licensed, volunteer health professionals the same protective standards included in the Volunteer Protection Act of 1997, your legislation takes critical steps to…
We are aware of the guidance the Centers for Medicare & Medicaid Services issued in its February 7, 2014 Q&A clarifying that it was not discouraging such subsidies from charitable foundations. Unfortunately, the Interim Final Rule issued on March 14 has created uncertainty regarding HHS’s…
FDA is aware that there has been an increase in demand for IV saline. Manufacturers of these products have reported that this increase in demand is linked to increased hospital use, which, long with other factors, resulted in a shortage of IV saline in January 2014.
The AHA strongly supports the conclusions and recommendations in the draft report and urges NQF to adopt them as soon as possible.
The AHA, ASHHRA and AONE believe that, in its current rulemaking, the Board has engaged in a process that is unwarranted, unprecedented and contrary to the administration‘s rulemaking goals by resubmitting, in essentially identical form, the Board‘s 2011 NPRM (See 76 Fed. Reg. 36,812).
The AHA supports the cautious exploration of a site-neutral payment policy that applies exclusively to patients who are clinically similar and can safely be treated in either setting.
We support CMS’s goal for Medicare providers and suppliers to have comprehensive emergency preparedness plans and generally think that CMS has chosen the correct framework for the proposed Conditions of Participation (CoPs) and Conditions for Coverage (CfCs).